Activin receptor type IIA (ActRIIA) drugs for Pulmonary Arterial Hypertension
2 tracked Activin receptor type IIA (ActRIIA) drugs in the Pulmonary Arterial Hypertension race. The class explanation lives on the Activin receptor type IIA (ActRIIA) page; the full indication pipeline across every mechanism is on the Pulmonary Arterial Hypertension page.
1 approved / phase 41 Phase 1/2
Head-to-head evidence: HS235 vs Sotatercept